"Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
出版信息
Eur Respir Rev. 2015 Sep;24(137):545. doi: 10.1183/09059180.50011514.
Abstract
摘要
相似文献
1
"Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
Eur Respir Rev. 2015 Sep;24(137):545. doi: 10.1183/09059180.50011514.
2
"Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. 2017; 26: 170050.
Eur Respir Rev. 2018 Apr 13;27(148). doi: 10.1183/16000617.5050-2017. Print 2018 Jun 30.
3
"Idiopathic inflammatory myopathies and the lung." Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216-238.“特发性炎性肌病与肺”。让 - 克里斯托夫·莱加、奎特里·雷诺、亚历山大·贝洛、妮可·法比安、伊莎贝尔·迪里厄和樊尚·科坦。《欧洲呼吸杂志综述》2015年；24: 216 - 238。
Eur Respir Rev. 2015 Sep;24(137):545. doi: 10.1183/16000617.50002015.
4
"Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis." Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776-1784.
Eur Respir J. 2016 Aug;48(2):593. doi: 10.1183/13993003.52087-2015.
5
"Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis." M. Kolb, B. Crestani and T.M. Maher. 2023; 32: 220206.磷酸二酯酶4B抑制：一种治疗肺纤维化的潜在新策略。M. 科尔布、B. 克雷斯塔尼和T.M. 马赫。2023年；32卷：220206。
Eur Respir Rev. 2024 Mar 27;33(171). doi: 10.1183/16000617.5206-2022. Print 2024 Jan 31.
6
"Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty." Vincent Cottin. Eur Respir J 2016; 48: 1274-1277.
Eur Respir J. 2016 Dec;48(6):1819. doi: 10.1183/13993003.51633-2016.
7
"Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease." Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci and Marc Humbert. 2019; 54: 1900585.
Eur Respir J. 2020 Jan 30;55(1). doi: 10.1183/13993003.50585-2019. Print 2020 Jan.
8
"Characterisation of patients with interstitial pneumonia with autoimmune features." Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. 2016; 47: 1767-1775.
Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.51565-2015. Print 2017 May.
9
Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.吡非尼酮治疗特发性肺纤维化的长期临床及真实世界经验。
Eur Respir Rev. 2015 Mar;24(135):58-64. doi: 10.1183/09059180.00011514.
10
Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg).评估吡非尼酮治疗特发性肺纤维化的有效性：来自欧洲特发性肺纤维化注册研究（eurIPFreg）的长期真实世界数据。
J Clin Med. 2020 Nov 22;9(11):3763. doi: 10.3390/jcm9113763.
Zotero 插件